Cargando…
Sirtuin 3 Activation by Honokiol Decreases Unilateral Ureteral Obstruction-Induced Renal Inflammation and Fibrosis via Regulation of Mitochondrial Dynamics and the Renal NF-κB-TGF-β1/Smad Signaling Pathway
Renal fibrosis is a common feature of all progressive chronic kidney diseases. Sirtuin 3 (SIRT3) is one of the mitochondrial sirtuins, and plays a role in the regulation of mitochondrial biogenesis, oxidative stress, fatty acid metabolism, and aging. Recently, honokiol (HKL), as a pharmaceutical SIR...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7014106/ https://www.ncbi.nlm.nih.gov/pubmed/31936371 http://dx.doi.org/10.3390/ijms21020402 |
_version_ | 1783496552784855040 |
---|---|
author | Quan, Yi Park, Woong Jin, Jixiu Kim, Won Park, Sung Kwang Kang, Kyung Pyo |
author_facet | Quan, Yi Park, Woong Jin, Jixiu Kim, Won Park, Sung Kwang Kang, Kyung Pyo |
author_sort | Quan, Yi |
collection | PubMed |
description | Renal fibrosis is a common feature of all progressive chronic kidney diseases. Sirtuin 3 (SIRT3) is one of the mitochondrial sirtuins, and plays a role in the regulation of mitochondrial biogenesis, oxidative stress, fatty acid metabolism, and aging. Recently, honokiol (HKL), as a pharmaceutical SIRT3 activator, has been observed to have a protective effect against pressure overload-induced cardiac hypertrophy by increasing SIRT3 activity. In this study, we investigated whether HKL, as a SIRT3 activator, also has protective effects against unilateral ureteral obstruction (UUO)-induced renal tubulointerstitial fibrosis through SIRT3-dependent regulation of mitochondrial dynamics and the nuclear factor-κB (NF-κB)/transforming growth factor-β1 (TGF-β1)/Smad signaling pathway. We found that HKL decreased the UUO-induced increase in tubular injury and extracellular matrix (ECM) deposition in mice. HKL also decreased myofibroblast activation and proliferation in UUO kidneys and NRK-49F cells. Finally, we showed that HKL treatment decreased UUO-induced mitochondrial fission and promoted mitochondrial fusion through SIRT3-dependent effects. In conclusion, activation of SIRT3 via HKL treatment might have beneficial effects on UUO-induced renal fibrosis through SIRT3-dependent regulation of mitochondrial dynamics and the NF-κB/TGF-β1/Smad signaling pathway. |
format | Online Article Text |
id | pubmed-7014106 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-70141062020-03-09 Sirtuin 3 Activation by Honokiol Decreases Unilateral Ureteral Obstruction-Induced Renal Inflammation and Fibrosis via Regulation of Mitochondrial Dynamics and the Renal NF-κB-TGF-β1/Smad Signaling Pathway Quan, Yi Park, Woong Jin, Jixiu Kim, Won Park, Sung Kwang Kang, Kyung Pyo Int J Mol Sci Article Renal fibrosis is a common feature of all progressive chronic kidney diseases. Sirtuin 3 (SIRT3) is one of the mitochondrial sirtuins, and plays a role in the regulation of mitochondrial biogenesis, oxidative stress, fatty acid metabolism, and aging. Recently, honokiol (HKL), as a pharmaceutical SIRT3 activator, has been observed to have a protective effect against pressure overload-induced cardiac hypertrophy by increasing SIRT3 activity. In this study, we investigated whether HKL, as a SIRT3 activator, also has protective effects against unilateral ureteral obstruction (UUO)-induced renal tubulointerstitial fibrosis through SIRT3-dependent regulation of mitochondrial dynamics and the nuclear factor-κB (NF-κB)/transforming growth factor-β1 (TGF-β1)/Smad signaling pathway. We found that HKL decreased the UUO-induced increase in tubular injury and extracellular matrix (ECM) deposition in mice. HKL also decreased myofibroblast activation and proliferation in UUO kidneys and NRK-49F cells. Finally, we showed that HKL treatment decreased UUO-induced mitochondrial fission and promoted mitochondrial fusion through SIRT3-dependent effects. In conclusion, activation of SIRT3 via HKL treatment might have beneficial effects on UUO-induced renal fibrosis through SIRT3-dependent regulation of mitochondrial dynamics and the NF-κB/TGF-β1/Smad signaling pathway. MDPI 2020-01-08 /pmc/articles/PMC7014106/ /pubmed/31936371 http://dx.doi.org/10.3390/ijms21020402 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Quan, Yi Park, Woong Jin, Jixiu Kim, Won Park, Sung Kwang Kang, Kyung Pyo Sirtuin 3 Activation by Honokiol Decreases Unilateral Ureteral Obstruction-Induced Renal Inflammation and Fibrosis via Regulation of Mitochondrial Dynamics and the Renal NF-κB-TGF-β1/Smad Signaling Pathway |
title | Sirtuin 3 Activation by Honokiol Decreases Unilateral Ureteral Obstruction-Induced Renal Inflammation and Fibrosis via Regulation of Mitochondrial Dynamics and the Renal NF-κB-TGF-β1/Smad Signaling Pathway |
title_full | Sirtuin 3 Activation by Honokiol Decreases Unilateral Ureteral Obstruction-Induced Renal Inflammation and Fibrosis via Regulation of Mitochondrial Dynamics and the Renal NF-κB-TGF-β1/Smad Signaling Pathway |
title_fullStr | Sirtuin 3 Activation by Honokiol Decreases Unilateral Ureteral Obstruction-Induced Renal Inflammation and Fibrosis via Regulation of Mitochondrial Dynamics and the Renal NF-κB-TGF-β1/Smad Signaling Pathway |
title_full_unstemmed | Sirtuin 3 Activation by Honokiol Decreases Unilateral Ureteral Obstruction-Induced Renal Inflammation and Fibrosis via Regulation of Mitochondrial Dynamics and the Renal NF-κB-TGF-β1/Smad Signaling Pathway |
title_short | Sirtuin 3 Activation by Honokiol Decreases Unilateral Ureteral Obstruction-Induced Renal Inflammation and Fibrosis via Regulation of Mitochondrial Dynamics and the Renal NF-κB-TGF-β1/Smad Signaling Pathway |
title_sort | sirtuin 3 activation by honokiol decreases unilateral ureteral obstruction-induced renal inflammation and fibrosis via regulation of mitochondrial dynamics and the renal nf-κb-tgf-β1/smad signaling pathway |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7014106/ https://www.ncbi.nlm.nih.gov/pubmed/31936371 http://dx.doi.org/10.3390/ijms21020402 |
work_keys_str_mv | AT quanyi sirtuin3activationbyhonokioldecreasesunilateralureteralobstructioninducedrenalinflammationandfibrosisviaregulationofmitochondrialdynamicsandtherenalnfkbtgfb1smadsignalingpathway AT parkwoong sirtuin3activationbyhonokioldecreasesunilateralureteralobstructioninducedrenalinflammationandfibrosisviaregulationofmitochondrialdynamicsandtherenalnfkbtgfb1smadsignalingpathway AT jinjixiu sirtuin3activationbyhonokioldecreasesunilateralureteralobstructioninducedrenalinflammationandfibrosisviaregulationofmitochondrialdynamicsandtherenalnfkbtgfb1smadsignalingpathway AT kimwon sirtuin3activationbyhonokioldecreasesunilateralureteralobstructioninducedrenalinflammationandfibrosisviaregulationofmitochondrialdynamicsandtherenalnfkbtgfb1smadsignalingpathway AT parksungkwang sirtuin3activationbyhonokioldecreasesunilateralureteralobstructioninducedrenalinflammationandfibrosisviaregulationofmitochondrialdynamicsandtherenalnfkbtgfb1smadsignalingpathway AT kangkyungpyo sirtuin3activationbyhonokioldecreasesunilateralureteralobstructioninducedrenalinflammationandfibrosisviaregulationofmitochondrialdynamicsandtherenalnfkbtgfb1smadsignalingpathway |